Etanercept treatment in corticosteroid-dependent myasthenia gravis

J. Rowin, M. N. Meriggioli, E. Tüzün, S. Leurgans, P. Christadoss

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

The authors report a prospective pilot trial of etanercept in corticosteroid-dependent autoimmune myasthenia gravis. Eleven patients were enrolled, with eight completing the 6-month trial. Two patients were withdrawn owing to disease worsening, and one patient was withdrawn because of an erythematous skin rash. Six of the eight patients who completed the trial improved, based on quantitative measures of muscle strength and lowering of corticosteroid requirement.

Original languageEnglish (US)
Pages (from-to)2390-2392
Number of pages3
JournalNeurology
Volume63
Issue number12
StatePublished - Dec 28 2004

Fingerprint

Myasthenia Gravis
Adrenal Cortex Hormones
Muscle Strength
Therapeutics
Exanthema
Etanercept

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Rowin, J., Meriggioli, M. N., Tüzün, E., Leurgans, S., & Christadoss, P. (2004). Etanercept treatment in corticosteroid-dependent myasthenia gravis. Neurology, 63(12), 2390-2392.

Etanercept treatment in corticosteroid-dependent myasthenia gravis. / Rowin, J.; Meriggioli, M. N.; Tüzün, E.; Leurgans, S.; Christadoss, P.

In: Neurology, Vol. 63, No. 12, 28.12.2004, p. 2390-2392.

Research output: Contribution to journalArticle

Rowin, J, Meriggioli, MN, Tüzün, E, Leurgans, S & Christadoss, P 2004, 'Etanercept treatment in corticosteroid-dependent myasthenia gravis', Neurology, vol. 63, no. 12, pp. 2390-2392.
Rowin J, Meriggioli MN, Tüzün E, Leurgans S, Christadoss P. Etanercept treatment in corticosteroid-dependent myasthenia gravis. Neurology. 2004 Dec 28;63(12):2390-2392.
Rowin, J. ; Meriggioli, M. N. ; Tüzün, E. ; Leurgans, S. ; Christadoss, P. / Etanercept treatment in corticosteroid-dependent myasthenia gravis. In: Neurology. 2004 ; Vol. 63, No. 12. pp. 2390-2392.
@article{e43a7c5c8e5b4876af253d5a9dbf18c4,
title = "Etanercept treatment in corticosteroid-dependent myasthenia gravis",
abstract = "The authors report a prospective pilot trial of etanercept in corticosteroid-dependent autoimmune myasthenia gravis. Eleven patients were enrolled, with eight completing the 6-month trial. Two patients were withdrawn owing to disease worsening, and one patient was withdrawn because of an erythematous skin rash. Six of the eight patients who completed the trial improved, based on quantitative measures of muscle strength and lowering of corticosteroid requirement.",
author = "J. Rowin and Meriggioli, {M. N.} and E. T{\"u}z{\"u}n and S. Leurgans and P. Christadoss",
year = "2004",
month = "12",
day = "28",
language = "English (US)",
volume = "63",
pages = "2390--2392",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "12",

}

TY - JOUR

T1 - Etanercept treatment in corticosteroid-dependent myasthenia gravis

AU - Rowin, J.

AU - Meriggioli, M. N.

AU - Tüzün, E.

AU - Leurgans, S.

AU - Christadoss, P.

PY - 2004/12/28

Y1 - 2004/12/28

N2 - The authors report a prospective pilot trial of etanercept in corticosteroid-dependent autoimmune myasthenia gravis. Eleven patients were enrolled, with eight completing the 6-month trial. Two patients were withdrawn owing to disease worsening, and one patient was withdrawn because of an erythematous skin rash. Six of the eight patients who completed the trial improved, based on quantitative measures of muscle strength and lowering of corticosteroid requirement.

AB - The authors report a prospective pilot trial of etanercept in corticosteroid-dependent autoimmune myasthenia gravis. Eleven patients were enrolled, with eight completing the 6-month trial. Two patients were withdrawn owing to disease worsening, and one patient was withdrawn because of an erythematous skin rash. Six of the eight patients who completed the trial improved, based on quantitative measures of muscle strength and lowering of corticosteroid requirement.

UR - http://www.scopus.com/inward/record.url?scp=11144331435&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=11144331435&partnerID=8YFLogxK

M3 - Article

VL - 63

SP - 2390

EP - 2392

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 12

ER -